The Anglo-Swedish company is facing challenges in distributing its Govt-19 vaccine and working to modify existing drugs to fight the virus.
AstraZeneca announced this Friday (20) that its antibody therapy has achieved the key goal of preventing Govit-19, paving the way for the British pharmaceutical company to offer an alternative route to people with vulnerable systems. Immune systems.
The company claims that a cocktail of two types of antibodies, first discovered by the University of Vanderbilt University Medical Center in the United States, has reduced the risk of developing symptomatic Covid-19 by 77%.
Astrogeneca explained that more than 75% of participants had chronic problems, some associated with a weakened immune response to the vaccine.
The results bring relief to the drugmaker, who announced in June that a low-level testing, antibody cocktail, now known as AZD7442, provided no evidence that it protected people infected with the new corona virus.
The Anglo-Swedish company is facing challenges in distributing its Govt-19 vaccine and working to modify existing drugs to fight the virus.
“Music geek. Coffee lover. Devoted food scholar. Web buff. Passionate internet guru.”
More Stories
Can turbulence bring down a plane? Understand that this is a real possibility!
10 Dangerous Foods for Your Puppy’s Health
Aggressive, hungry pythons move north from Florida – International